HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients.

AbstractBACKGROUND:
Hepatitis B surface antigen (HBsAg) seroconversion in HBeAg -ve chronic hepatitis B (CHB) infection is rare, possibly due to poor antigen processing and impaired humoral response. We investigated the role of dendritic cells (DCs), T follicular helper (TFH) cells and plasma B cells in seroconversion.
METHODS:
HBeAg -ve (n=135) CHB patients with raised ALT at baseline were followed up. Patients undergoing HBsAg seroconversion (Gr. I, n=11) were compared with non-converters with low (Gr. II, n=17, HBV DNA<2000 IU/mL) or high HBV DNA (Gr. III, HBV DNA >2000 IU/mL, n=17). We measured cell phenotypes (TFH, B and DCs), HBV specific T-cell functionality [using pooled overlapping surface and core peptides], IL21 levels and gene expression analysis by qRT-PCR.
RESULTS:
Patients in Gr. I compared to Gr. II and III, had higher IL-21 levels (865 vs 276 vs 111 pg/mL, P=<.0001), TFH (CD4+ CXCR5+ ) cells (12.3 vs 4.67 vs 2.77, P=<.001), inducible T-cell co-stimulator (ICOS) expression on TFH cells (20.0 vs 13.0 vs 13.68, P=.01), HBsAg specific IL-17 (9.40 vs 2.33 vs 2.61, P=<.001) and TNF-α secreting TFH17 cells (82 vs 1.43 vs 2.33, P=<.001), plasma B (CD19+ CD38+ ) cells (15.0 vs 5.08 vs 5.57, P=<.001), myeloid (17.80 vs 5.39 vs 2.70, P=<.001) and plasmocytoid DCs (2.6 vs 0.43 vs 0.21, P=<.001). Plasma B-cell frequency (R2 =.64, P=.01) and IL-21 levels (R2 =.52, P=.003) correlated with anti-HBs titres in patients with HBsAg seroconversion.
CONCLUSIONS:
Dendritic cell and TFH cell mediated responses regulate humoral responses against HBV and play a major role in HBsAg seroconversion in CHB patients.
AuthorsAshish Kumar Vyas, Barjesh Chander Sharma, Shiv Kumar Sarin, Nirupma Trehanpati
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 38 Issue 1 Pg. 38-49 (01 2018) ISSN: 1478-3231 [Electronic] United States
PMID28500636 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Chemical References
  • Biomarkers
  • DNA, Viral
  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • ICOS protein, human
  • Inducible T-Cell Co-Stimulator Protein
  • Interleukins
  • TLR7 protein, human
  • Toll-Like Receptor 7
  • interleukin-21
Topics
  • B-Lymphocytes (immunology, virology)
  • Biomarkers (blood)
  • Cells, Cultured
  • DNA, Viral (blood, genetics)
  • Dendritic Cells (immunology, virology)
  • Hepatitis B Antibodies (blood, immunology)
  • Hepatitis B Surface Antigens (immunology)
  • Hepatitis B e Antigens (immunology)
  • Hepatitis B virus (genetics, immunology)
  • Hepatitis B, Chronic (blood, diagnosis, immunology, virology)
  • Host-Pathogen Interactions
  • Humans
  • Immunity, Humoral
  • Inducible T-Cell Co-Stimulator Protein (immunology)
  • Interleukins (immunology)
  • Seroconversion
  • T-Lymphocytes, Helper-Inducer (immunology, virology)
  • Toll-Like Receptor 7 (immunology)
  • Viral Load

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: